“Rheumatoid Factor Positivity Rather Than Anti-CCP Positivity, a Lower Disability and a Lower Number of Anti-TNFα Agents Failed Are Associated With Response to Rituximab in Rheumatoid Arthritis”. Reumatismo, vol. 61, no. 3, Sept. 2009, pp. 182-6, https://doi.org/10.4081/reumatismo.2009.182.